US Stock MarketDetailed Quotes

RPRX Royalty Pharma

Watchlist
  • 28.000
  • -0.110-0.39%
Close Apr 26 16:00 ET
  • 28.000
  • 0.0000.00%
Post 17:32 ET
12.63BMarket Cap11.07P/E (TTM)

Royalty Pharma Key Stats

Royalty Pharma Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings Estimates

May 9, 2024

Revenue(YoY)

694.58M

+1.55%
EPS(YoY)

0.54

0.00%

Strong Buy

Apr 12, 2024

Royalty Pharma Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 628.804M--
May 9, 20242024/Q1-- / 694.584M--
Feb 15, 20242023/Q4596.000M / 674.541M--
Nov 8, 20232023/Q3536.313M / 618.492M--
Aug 8, 20232023/Q2538.000M / 536.594M--
May 9, 20232023/Q1684.000M / 629.653M--
Feb 15, 20232022/Q4566.000M / 1.097B--
Nov 8, 20222022/Q3573.000M / 610.321M--
Aug 4, 20222022/Q2536.000M / 533.903M--
May 5, 20222022/Q1562.000M / 592.966M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 628.804M--
May 9, 20242024/Q1-- / 694.584M--
Feb 15, 20242023/Q4596.000M / 674.541M--
Nov 8, 20232023/Q3536.313M / 618.492M--
Aug 8, 20232023/Q2538.000M / 536.594M--
May 9, 20232023/Q1684.000M / 629.653M--
Feb 15, 20232022/Q4566.000M / 1.097B--
Nov 8, 20222022/Q3573.000M / 610.321M--
Aug 4, 20222022/Q2536.000M / 533.903M--
May 5, 20222022/Q1562.000M / 592.966M--

Unlock Free Earnings Estimates

Royalty Pharma Earnings Reports

Read more

Analysis

Analyst Rating

Updated: Apr 12, 2024

Strong Buy

  • Buy

    100.00%
  • Hold

    0.00%
  • Sell

    0.00%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg